Figure 2. Proportion of MRA‐eligible patients with STEMI* with MRA prescription at discharge by calendar year*†.
*MRA‐eligible patients with STEMI: Left ventricular ejection fraction ≤40% plus either clinical heart failure or prior history of diabetes mellitus, and without dialysis‐dependent renal dysfunction. †n denotes the number of MRA‐eligible patients with STEMI in that year. MRA indicates mineralocorticoid receptor antagonist; and STEMI, ST‐segment–elevation myocardial infarction.